Literature DB >> 35866917

Necrotizing fasciitis with slow progression in a patient with rheumatoid arthritis receiving tocilizumab

Kazuya Goto1, Toshiaki Kogame1, Nobuhiro Kusuba1, Yuichiro Endo1, Teruki Dainichi1,2, Kenji Kabashima1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35866917      PMCID： PMC9463966          DOI： 10.1684/ejd.2022.4249

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   2.805


× No keyword cloud information.
  10 in total

1.  Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection.

Authors:  A Norrby-Teglund; S Chatellier; D E Low; A McGeer; K Green; M Kotb
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

Review 2.  Necrotizing fasciitis.

Authors:  Taro Shimizu; Yasuharu Tokuda
Journal:  Intern Med       Date:  2010-06-15       Impact factor: 1.271

3.  Necrotizing fasciitis in a patient receiving tocilizumab for rheumatoid arthritis - Case report.

Authors:  Diana Rosa-Gonçalves; Miguel Bernardes; Lúcia Costa
Journal:  Reumatol Clin (Engl Ed)       Date:  2016-12-29

4.  Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.

Authors:  Loren G Miller; Francoise Perdreau-Remington; Gunter Rieg; Sheherbano Mehdi; Josh Perlroth; Arnold S Bayer; Angela W Tang; Tieu O Phung; Brad Spellberg
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

5.  Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.

Authors:  Ajinkya Pawar; Rishi J Desai; Daniel H Solomon; Adrian J Santiago Ortiz; Sara Gale; Min Bao; Khaled Sarsour; Sebastian Schneeweiss; Seoyoung C Kim
Journal:  Ann Rheum Dis       Date:  2019-01-24       Impact factor: 19.103

6.  Necrotising soft tissue infection without systemic toxicity in a patient with rheumatoid arthritis treated with tocilizumab.

Authors:  Saki Manabe; Hidetaka Yanagi; Hideki Ozawa; Atsushi Takagi
Journal:  BMJ Case Rep       Date:  2017-12-15

7.  [Necrotizing Soft Tissue Infection Caused by Serratia marcescens in a Patient Treated with Tocilizumab].

Authors:  Hiroo Matsuo; Kyoko Kosaka; Kentaro Iwata; Goh Ohji
Journal:  Kansenshogaku Zasshi       Date:  2015-01

Review 8.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Authors:  Filip De Keyser
Journal:  Curr Rheumatol Rev       Date:  2011-02

10.  Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.

Authors:  Shruti Gupta; Wei Wang; Salim S Hayek; Lili Chan; Kusum S Mathews; Michal L Melamed; Samantha K Brenner; Amanda Leonberg-Yoo; Edward J Schenck; Jared Radbel; Jochen Reiser; Anip Bansal; Anand Srivastava; Yan Zhou; Diana Finkel; Adam Green; Mary Mallappallil; Anthony J Faugno; Jingjing Zhang; Juan Carlos Q Velez; Shahzad Shaefi; Chirag R Parikh; David M Charytan; Ambarish M Athavale; Allon N Friedman; Roberta E Redfern; Samuel A P Short; Simon Correa; Kapil K Pokharel; Andrew J Admon; John P Donnelly; Hayley B Gershengorn; David J Douin; Matthew W Semler; Miguel A Hernán; David E Leaf
Journal:  JAMA Intern Med       Date:  2021-01-01       Impact factor: 21.873
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.